BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 3108684)

  • 1. Haemolytic-uraemic syndrome associated with mitomycin-C treatment.
    Wils J; Grave W; van Breda Vriesman PJ
    Neth J Med; 1987 Feb; 30(1-2):32-5. PubMed ID: 3108684
    [No Abstract]   [Full Text] [Related]  

  • 2. Two patients suffering from interstitial pneumonitis and haemolytic-uraemic syndrome as side effects of mitomycin C therapy.
    van Spreeuwel JP; Hemrika MH; de Maat CE; Nadorp JH
    Neth J Med; 1983; 26(9):287-8. PubMed ID: 6419134
    [No Abstract]   [Full Text] [Related]  

  • 3. Mitomycin C: interstitial pneumonitis and haemolytic-uraemic syndrome.
    Boven E; Pinedo HM
    Neth J Med; 1983; 26(6):153-6. PubMed ID: 6412148
    [No Abstract]   [Full Text] [Related]  

  • 4. Two patients with a fatal haemolytic-uremic syndrome after combination therapy including mitomycin C.
    Boven E; Pinedo HM
    Neth J Med; 1983; 26(9):288. PubMed ID: 6419135
    [No Abstract]   [Full Text] [Related]  

  • 5. Pulmonary angiomatoid vascular changes in mitomycin C-associated hemolytic-uremic syndrome.
    Chang-Poon VY; Hwang WS; Wong A; Berry J; Klassen J; Poon MC
    Arch Pathol Lab Med; 1985 Sep; 109(9):877-8. PubMed ID: 3927871
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Uremic hemolytic syndrome induced by mitomycin C. Presentation of a series of 5 cases and review of the literature].
    Nicolás JM; Villalta J; González-Clemente JM; Antúnez E; Almirall J; Bosch J; Torras A; Urbano-Márquez A
    Rev Clin Esp; 1990 Mar; 186(4):166-70. PubMed ID: 2114657
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Chemotherapy-induced hemolytic uremic syndrome. A complication to mitomycin treatment of breast carcinoma].
    Schjølseth SA; Hagen T; Ottestad L; Jakobsen E
    Tidsskr Nor Laegeforen; 1995 Nov; 115(27):3371-3. PubMed ID: 7491579
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Hemolytic-uremic syndrome caused by mitomycin C].
    de Insausti CL; Gutiérrez LE
    Sangre (Barc); 1988 Aug; 33(4):319-20. PubMed ID: 3142062
    [No Abstract]   [Full Text] [Related]  

  • 9. Hemolytic-uremic syndrome in a patient receiving mitomycin C and 5-fluorouracil.
    Willie GR; Levy SM; Michaels RS; Zirkin RM
    Henry Ford Hosp Med J; 1983; 31(2):104-9. PubMed ID: 6313552
    [No Abstract]   [Full Text] [Related]  

  • 10. Mitomycin C-induced pulmonary and renal toxicities.
    Loprinzi CL
    Wis Med J; 1984 Mar; 83(3):16-7. PubMed ID: 6428065
    [No Abstract]   [Full Text] [Related]  

  • 11. Mitomycin-induced hemolytic uremic syndrome: case presentation and review of literature.
    Rabadi SJ; Khandekar JD; Miller HJ
    Cancer Treat Rep; 1982 May; 66(5):1244-7. PubMed ID: 7083229
    [No Abstract]   [Full Text] [Related]  

  • 12. Hemolytic-uremic syndrome associated with mitomycin therapy.
    Pavy MD; Wiley EL; Abeloff MD
    Cancer Treat Rep; 1982 Mar; 66(3):457-61. PubMed ID: 7060035
    [No Abstract]   [Full Text] [Related]  

  • 13. Haemolytic-uraemic syndrome complicating long-term mitomycin C and 5-fluorouracil therapy for gastric carcinoma.
    Crocker J; Jones EL
    J Clin Pathol; 1983 Jan; 36(1):24-9. PubMed ID: 6401771
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Female with breast cancer, undergoing chemotherapeutic treatment hospitalized because of general deterioration, anemia and renal insufficiency].
    Rev Clin Esp; 1990 Jun; 187(2):82-8. PubMed ID: 2123041
    [No Abstract]   [Full Text] [Related]  

  • 15. [Nephrotoxicity of mitomycin C (apropos of 25 case reports). Results of a multicenter survey organized by the Society of Nephrology].
    Cordonnier D; Vert-Pré FC; Bayle F; Alix JL; Couderc P
    Nephrologie; 1985; 6(1):19-26. PubMed ID: 3923381
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of mitomycin-C-associated hemolytic uremic syndrome with plasmapheresis.
    Poch E; Almirall J; Nicolas JM; Torras A; Revert L
    Nephron; 1990; 55(1):89-90. PubMed ID: 2112726
    [No Abstract]   [Full Text] [Related]  

  • 17. Cancer-associated hemolytic uremic syndrome: a possible role of mitomycin in relation to Shiga-like toxins.
    Acheson DW; Donohue-Rolfe A
    J Clin Oncol; 1989 Dec; 7(12):1943. PubMed ID: 2511278
    [No Abstract]   [Full Text] [Related]  

  • 18. Hemolytic-uremic syndrome after cancer chemotherapy without mitomycin C.
    Desablens B; Fievet P; Pruna A; Claisse JF; Westeel PF; Tolani M; Fournier A
    Nephron; 1986; 42(4):343-4. PubMed ID: 3083278
    [No Abstract]   [Full Text] [Related]  

  • 19. [Anatomo-clinical conference. Hôpital de la Pitié-Salpêtrière. Case n. 2-1987. Anemia, thrombopenia and renal insufficiency in a patient treated for cancer of the pancreas].
    Follezou JY; Baumelou A; Audebert A; Beaufils H; Karkouche B
    Ann Med Interne (Paris); 1987; 138(4):308-14. PubMed ID: 3115166
    [No Abstract]   [Full Text] [Related]  

  • 20. Mitomycin-induced hemolytic-uremic syndrome.
    Proia AD; Harden EA; Silberman HR
    Arch Pathol Lab Med; 1984 Dec; 108(12):959-62. PubMed ID: 6210069
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.